Corrigendum to "CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma" Neoplasia, October 2018, Volume 20, Issue 10, Pages 1070-1082

Affiliations

¹ Laboratory of Tumor Angiogenesis, Georgia Cancer Center, Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA.
² Department of Chemistry and Physics, Augusta University, Augusta, GA.
³ Department of Pathology, Augusta University, Augusta, GA.
⁴ Laboratory of Tumor Angiogenesis, Georgia Cancer Center, Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA. Electronic address: aarbab@augusta.edu.

Published Erratum

Kartik Angara et al. Neoplasia. 2019 Jan.

. 2019 Jan;21(1):156-157.

doi: 10.1016/j.neo.2018.11.001.

¹ Laboratory of Tumor Angiogenesis, Georgia Cancer Center, Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA.
² Department of Chemistry and Physics, Augusta University, Augusta, GA.
³ Department of Pathology, Augusta University, Augusta, GA.
⁴ Laboratory of Tumor Angiogenesis, Georgia Cancer Center, Department of Biochemistry and Molecular Biology, Augusta University, Augusta, GA. Electronic address: aarbab@augusta.edu.

No abstract available

Figures

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.
Angara K, Borin TF, Rashid MH, Lebedyeva I, Ara R, Lin PC, Iskander A, Bollag RJ, Achyut BR, Arbab AS. Angara K, et al. Neoplasia. 2018 Oct;20(10):1070-1082. doi: 10.1016/j.neo.2018.08.011. Neoplasia. 2018. PMID: 30236892 Free PMC article.